PDS Biotechnology Corpora... (PDSB)
1.47
0.08 (5.76%)
At close: Jan 15, 2025, 9:53 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -42.94M | -40.85M | -16.92M | -14.85M | -7.00M | -40.87M | -50.86M | -38.82M | -28.08M | -12.20M | -6.88M | -4.70M |
| Depreciation & Amortization | 17.36K | 86.00 | 5.36K | 15.61K | 98.41K | 174.35K | 182.92K | 100.12K | 53.12K | 31.23K | 4.44K | 2.18K |
| Stock-Based Compensation | 7.61M | 5.20M | 4.11M | 452.29K | 3.18M | 7.61M | 6.40M | 5.31M | 2.90M | 1.30M | 260.36K | n/a |
| Other Working Capital | -5.96M | 4.57M | 181.64K | 852.16K | -2.63M | 541.19K | 2.18M | -638.12K | 1.33M | 1.17M | -619.53K | 2.10M |
| Other Non-Cash Items | 3.84M | 5.47M | 241.03K | 160.68K | -9.36M | 531.67K | 363.91K | 175.91K | 1.92M | -575.98K | 854.34K | 348.17K |
| Deferred Income Tax | -1.97M | n/a | n/a | n/a | -381.51K | 2.82M | 141.28K | 268.80K | 198.96K | 35.29K | n/a | n/a |
| Change in Working Capital | -199.28K | 4.47M | 75.82K | 1.07M | -4.60M | -3.43M | 3.07M | 782.43K | 1.26M | 1.70M | -2.28M | 2.10M |
| Operating Cash Flow | -33.64M | -25.71M | -12.49M | -13.15M | -18.07M | -33.15M | -40.70M | -32.19M | -21.75M | -9.72M | -8.04M | -2.25M |
| Capital Expenditures | -4 | n/a | n/a | n/a | n/a | n/a | -188.72K | -686.71K | -1.31M | -884.79K | -136.89K | -611 |
| Acquisitions | n/a | n/a | n/a | n/a | 29.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | 275.00K | n/a | n/a | -687.00K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | 29.38M | n/a | -188.72K | -686.71K | -1.31M | -884.79K | -136.89K | -612 |
| Debt Repayment | -59.30K | 25.00M | n/a | n/a | n/a | -15.56K | 5.00M | 9.53M | 2.47M | 1.55M | 100.00K | 150.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.05K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 308.94K | -568.87K | 344.13K | 70.46K | n/a | 1.51M | 171.34K | -219.04K | 50.99M | 14.92M | 15.82M | n/a |
| Financial Cash Flow | 16.38M | 34.29M | 48.89M | 29.83M | 750.00K | -20.27M | 22.55M | 9.08M | 139.52M | 16.47M | 15.90M | 2.37M |
| Net Cash Flow | -17.26M | 8.58M | 36.40M | 16.68M | 12.06M | -53.42M | -18.33M | -23.79M | 116.46M | 5.87M | 7.72M | n/a |
| Free Cash Flow | -33.64M | -25.71M | -12.49M | -13.15M | -18.07M | -33.15M | -40.89M | -32.88M | -23.06M | -10.60M | -8.18M | -2.25M |